MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDACA55293N1096

Current stock price

41.31 CAD
-0.88 (-2.09%)
Last:

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MDA was profitable.
  • In the past year MDA had a positive cash flow from operations.
  • Of the past 5 years MDA 4 years were profitable.
  • In the past 5 years MDA always reported a positive cash flow from operatings.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • With a Return On Assets value of 3.15%, MDA is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • MDA has a better Return On Equity (8.24%) than 84.62% of its industry peers.
  • MDA's Return On Invested Capital of 5.12% is on the low side compared to the rest of the industry. MDA is outperformed by 61.54% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MDA is significantly below the industry average of 9.48%.
  • The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROIC 5.12%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.40%, MDA is doing worse than 61.54% of the companies in the same industry.
  • MDA's Profit Margin has improved in the last couple of years.
  • The Operating Margin of MDA (9.86%) is worse than 61.54% of its industry peers.
  • MDA's Operating Margin has improved in the last couple of years.
  • MDA's Gross Margin of 24.62% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
  • MDA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30

5

2. MDA.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
  • MDA has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for MDA has been reduced compared to a year ago.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.92 indicates that MDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 1.92, MDA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
  • MDA has a Debt to FCF ratio of 0.92. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
  • The Debt to Equity ratio of MDA (0.31) is better than 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Altman-Z 1.92
ROIC/WACC0.56
WACC9.13%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
  • MDA's Current ratio of 0.55 is on the low side compared to the rest of the industry. MDA is outperformed by 84.62% of its industry peers.
  • A Quick Ratio of 0.54 indicates that MDA may have some problems paying its short term obligations.
  • MDA has a Quick ratio (0.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.54
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. MDA.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.25% over the past year.
  • The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
  • Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 57.77%.
  • MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%

3.2 Future

  • MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.13% yearly.
  • The Revenue is expected to grow by 23.86% on average over the next years. This is a very strong growth
EPS Next Y104.89%
EPS Next 2Y46.99%
EPS Next 3Y35.13%
EPS Next 5YN/A
Revenue Next Year51.69%
Revenue Next 2Y29.67%
Revenue Next 3Y23.86%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

3

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MDA is valuated quite expensively with a Price/Earnings ratio of 36.56.
  • Based on the Price/Earnings ratio, MDA is valued a bit more expensive than 69.23% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, MDA is valued a bit more expensive.
  • The Price/Forward Earnings ratio is 27.31, which means the current valuation is very expensive for MDA.
  • Based on the Price/Forward Earnings ratio, MDA is valued a bit more expensive than 61.54% of the companies in the same industry.
  • MDA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.56
Fwd PE 27.31
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.19
EV/EBITDA 21.03
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MDA's earnings are expected to grow with 35.13% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y46.99%
EPS Next 3Y35.13%

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • MDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (3/13/2026, 7:00:00 PM)

41.31

-0.88 (-2.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap5.22B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts80
Price Target48.2 (16.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)2.59%
PT rev (3m)22.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.6%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-0.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 36.56
Fwd PE 27.31
P/S 3.53
P/FCF 11.19
P/OCF 7.1
P/B 3.93
P/tB N/A
EV/EBITDA 21.03
EPS(TTM)1.13
EY2.74%
EPS(NY)1.51
Fwd EY3.66%
FCF(TTM)3.69
FCFY8.93%
OCF(TTM)5.82
OCFY14.09%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.35
PEG (5Y)N/A
Graham Number16.35
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 8.24%
ROCE 7.1%
ROIC 5.12%
ROICexc 5.66%
ROICexgc 60.4%
OM 9.86%
PM (TTM) 7.4%
GM 24.62%
FCFM 31.5%
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.92
Debt/EBITDA 1.55
Cap/Depr 226.87%
Cap/Sales 18.19%
Interest Coverage 9.36
Cash Conversion 277.94%
Profit Quality 425.55%
Current Ratio 0.55
Quick Ratio 0.54
Altman-Z 1.92
F-Score6
WACC9.13%
ROIC/WACC0.56
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y104.89%
EPS Next 2Y46.99%
EPS Next 3Y35.13%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year51.69%
Revenue Next 2Y29.67%
Revenue Next 3Y23.86%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year181.9%
EBIT Next 3Y51.76%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A

MDA SPACE LTD / MDA.CA Fundamental Analysis FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 5 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 3 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


What is the profitability of MDA stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


What is the financial health of MDA SPACE LTD (MDA.CA) stock?

The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.


What is the earnings growth outlook for MDA SPACE LTD?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 104.89% in the next year.